AU5251499A - Compositions and methods useful for treatment of depressive disorder based on ananimal model - Google Patents

Compositions and methods useful for treatment of depressive disorder based on ananimal model

Info

Publication number
AU5251499A
AU5251499A AU52514/99A AU5251499A AU5251499A AU 5251499 A AU5251499 A AU 5251499A AU 52514/99 A AU52514/99 A AU 52514/99A AU 5251499 A AU5251499 A AU 5251499A AU 5251499 A AU5251499 A AU 5251499A
Authority
AU
Australia
Prior art keywords
ananimal
compositions
treatment
model
depressive disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52514/99A
Inventor
Fraser Aird
Eva Redei
Leah Solberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwestern University
Original Assignee
Northwestern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwestern University filed Critical Northwestern University
Publication of AU5251499A publication Critical patent/AU5251499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU52514/99A 1998-10-23 1999-08-03 Compositions and methods useful for treatment of depressive disorder based on ananimal model Abandoned AU5251499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10545998P 1998-10-23 1998-10-23
US60105459 1998-10-23
PCT/US1999/017513 WO2000024875A1 (en) 1998-10-23 1999-08-03 Compositions and methods useful for treatment of depressive disorder based on an animal model

Publications (1)

Publication Number Publication Date
AU5251499A true AU5251499A (en) 2000-05-15

Family

ID=22305974

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52514/99A Abandoned AU5251499A (en) 1998-10-23 1999-08-03 Compositions and methods useful for treatment of depressive disorder based on ananimal model

Country Status (2)

Country Link
AU (1) AU5251499A (en)
WO (1) WO2000024875A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001265268A1 (en) * 2000-06-01 2001-12-11 Pharmacia And Upjohn Company Mice heterozygous for wfs1 gene as mouse models for depression
CN112167163A (en) * 2020-09-03 2021-01-05 中国人民解放军63919部队 Preparation method of animal model for treating spaceflight depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU704838B2 (en) * 1994-09-12 1999-05-06 Trustees Of The University Of Pennsylvania, The Corticotropin release inhibiting factor and methods of using same
US5668141A (en) * 1996-04-02 1997-09-16 Abbott Laboratories Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonists
US5866412A (en) * 1997-03-27 1999-02-02 Millennium Pharmaceuticals, Inc. Chromosome 18 marker

Also Published As

Publication number Publication date
WO2000024875A1 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
AU6872498A (en) Method and composition for skin treatment
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2336399A (en) Methods and apparatus for activating dental compositions
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU3387599A (en) Methods and compositions for tissue regeneration
PL327658A1 (en) Disinfecting compositions and methods of disinfecting surfaces
AU5763900A (en) Methods of enriching for and identifying polymorphisms
AU2113295A (en) Novel compositions and methods for water treatment
AU2327599A (en) Compositions and methods for treating autoimmune diseases
PL327945A1 (en) Disinfecting compositions and methods of disinfecting surfaces
AU9016898A (en) Methods and compositions for treatment of restenosis
AUPP489798A0 (en) Hair growth/maintenance compositions and methods
AU3065999A (en) Compositions and methods for treatment of asthma
AU2668699A (en) Methods and compositions for modulating leptin activity
AU3768795A (en) Method and compositions for hair treatment
AU3204899A (en) Hair treatment composition and method
IL141426A0 (en) Compositions and methods for the treatment of tumor
AU3569099A (en) Live vaccines and methods of treatment therewith
IL143212A0 (en) Compositions and methods for the treatment of tumor
EP1139981A4 (en) Compositions and methods of using the same
AU3127795A (en) Composition and treatment for baldness
AU6252699A (en) Composition and method for treating allergic diseases
AU5251499A (en) Compositions and methods useful for treatment of depressive disorder based on ananimal model
AU2420101A (en) Method and composition for the treatment of pain
AU2221400A (en) Compositions containing and methods of using n-acyl-1h-aminoindenes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase